Logo image of SENS

SENSEONICS HOLDINGS INC (SENS) Stock Fundamental Analysis

NYSEARCA:SENS - American Stock Exchange - US81727U1051 - Common Stock

0.9054  +0.06 (+6.78%)

Premarket: 0.8916 -0.01 (-1.52%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to SENS. SENS was compared to 191 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of SENS have multiple concerns. SENS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

SENS had negative earnings in the past year.
In the past year SENS has reported a negative cash flow from operations.
In the past 5 years SENS reported 4 times negative net income.
In the past 5 years SENS always reported negative operating cash flow.
SENS Yearly Net Income VS EBIT VS OCF VS FCFSENS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M -200M -300M

1.2 Ratios

SENS's Return On Assets of -72.12% is on the low side compared to the rest of the industry. SENS is outperformed by 75.79% of its industry peers.
SENS's Return On Equity of -210.43% is on the low side compared to the rest of the industry. SENS is outperformed by 77.37% of its industry peers.
Industry RankSector Rank
ROA -72.12%
ROE -210.43%
ROIC N/A
ROA(3y)-38.59%
ROA(5y)-138.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SENS Yearly ROA, ROE, ROICSENS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1K -1K

1.3 Margins

SENS has a worse Gross Margin (12.04%) than 81.05% of its industry peers.
The Profit Margin and Operating Margin are not available for SENS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 12.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SENS Yearly Profit, Operating, Gross MarginsSENS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5K -10K

More info and screens

3

2. Health

2.1 Basic Checks

SENS does not have a ROIC to compare to the WACC, probably because it is not profitable.
SENS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SENS has been increased compared to 5 years ago.
The debt/assets ratio for SENS has been reduced compared to a year ago.
SENS Yearly Shares OutstandingSENS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M
SENS Yearly Total Debt VS Total AssetsSENS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

SENS has an Altman-Z score of -8.20. This is a bad value and indicates that SENS is not financially healthy and even has some risk of bankruptcy.
SENS has a worse Altman-Z score (-8.20) than 77.37% of its industry peers.
A Debt/Equity ratio of 0.89 indicates that SENS is somewhat dependend on debt financing.
SENS has a worse Debt to Equity ratio (0.89) than 75.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Altman-Z -8.2
ROIC/WACCN/A
WACC8.86%
SENS Yearly LT Debt VS Equity VS FCFSENS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M -100M -150M

2.3 Liquidity

A Current Ratio of 3.11 indicates that SENS has no problem at all paying its short term obligations.
SENS has a Current ratio (3.11) which is comparable to the rest of the industry.
SENS has a Quick Ratio of 2.89. This indicates that SENS is financially healthy and has no problem in meeting its short term obligations.
SENS has a better Quick ratio (2.89) than 63.68% of its industry peers.
Industry RankSector Rank
Current Ratio 3.11
Quick Ratio 2.89
SENS Yearly Current Assets VS Current LiabilitesSENS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

SENS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -30.00%.
The Revenue has grown by 11.41% in the past year. This is quite good.
Measured over the past years, SENS shows a small growth in Revenue. The Revenue has been growing by 3.43% on average per year.
EPS 1Y (TTM)-30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)11.41%
Revenue growth 3Y65.39%
Revenue growth 5Y3.43%
Sales Q2Q%-30.08%

3.2 Future

The Earnings Per Share is expected to grow by 4.42% on average over the next years.
The Revenue is expected to grow by 28.96% on average over the next years. This is a very strong growth
EPS Next Y9.56%
EPS Next 2Y8.06%
EPS Next 3Y4.42%
EPS Next 5YN/A
Revenue Next Year0.7%
Revenue Next 2Y27.41%
Revenue Next 3Y28.96%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SENS Yearly Revenue VS EstimatesSENS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
SENS Yearly EPS VS EstimatesSENS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 -0.4 -0.6 -0.8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SENS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SENS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SENS Price Earnings VS Forward Price EarningsSENS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SENS Per share dataSENS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.06%
EPS Next 3Y4.42%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SENS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SENSEONICS HOLDINGS INC

NYSEARCA:SENS (1/21/2025, 8:26:11 PM)

Premarket: 0.8916 -0.01 (-1.52%)

0.9054

+0.06 (+6.78%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners10.99%
Inst Owner Change-0.02%
Ins Owners4.66%
Ins Owner Change-0.41%
Market Cap539.01M
Analysts50
Price Target1.43 (57.94%)
Short Float %7.64%
Short Ratio3.54
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.16%
Min EPS beat(2)1.96%
Max EPS beat(2)4.35%
EPS beat(4)3
Avg EPS beat(4)6.73%
Min EPS beat(4)-8.93%
Max EPS beat(4)29.55%
EPS beat(8)4
Avg EPS beat(8)-5.71%
EPS beat(12)8
Avg EPS beat(12)81.53%
EPS beat(16)8
Avg EPS beat(16)-132.5%
Revenue beat(2)1
Avg Revenue beat(2)1.95%
Min Revenue beat(2)-3.55%
Max Revenue beat(2)7.45%
Revenue beat(4)3
Avg Revenue beat(4)4.59%
Min Revenue beat(4)-3.55%
Max Revenue beat(4)9.28%
Revenue beat(8)6
Avg Revenue beat(8)4.33%
Revenue beat(12)7
Avg Revenue beat(12)1.75%
Revenue beat(16)11
Avg Revenue beat(16)7.88%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.92%
Revenue NY rev (3m)-0.92%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 22.42
P/FCF N/A
P/OCF N/A
P/B 14.1
P/tB 14.1
EV/EBITDA N/A
EPS(TTM)-0.13
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS0.04
BVpS0.06
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -72.12%
ROE -210.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 12.04%
FCFM N/A
ROA(3y)-38.59%
ROA(5y)-138.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 202.17%
Cap/Sales 11.24%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.11
Quick Ratio 2.89
Altman-Z -8.2
F-Score3
WACC8.86%
ROIC/WACCN/A
Cap/Depr(3y)25.34%
Cap/Depr(5y)39.26%
Cap/Sales(3y)1.67%
Cap/Sales(5y)2.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y9.56%
EPS Next 2Y8.06%
EPS Next 3Y4.42%
EPS Next 5YN/A
Revenue 1Y (TTM)11.41%
Revenue growth 3Y65.39%
Revenue growth 5Y3.43%
Sales Q2Q%-30.08%
Revenue Next Year0.7%
Revenue Next 2Y27.41%
Revenue Next 3Y28.96%
Revenue Next 5YN/A
EBIT growth 1Y2.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3.5%
EBIT Next 3Y6.54%
EBIT Next 5YN/A
FCF growth 1Y-10.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6.2%
OCF growth 3YN/A
OCF growth 5YN/A